Shane works closely with his colleagues in Business Development and throughout the R&D organization to identify and engage with external collaborators in industry and academia to license or acquire promising preclinical programs or technologies with therapeutic potential for aging-related diseases such as cancer.
Why Shane works at Calico
"I get to interface with our entire research organization and also external collaborators to prioritize emerging science and technologies, and to help build Calico’s therapeutic pipeline. Calico enables me to be a part of the next wave of novel therapeutics and potentially make a meaningful impact for patients with cancer, neurodegeneration or other aging-related diseases."
Director, Business Development
Calico is currently seeking exceptional candidates who share our passion for understanding the science of aging and developing therapeutics to address age-related diseases.